# Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

> **NCT00416910** · PHASE3 · TERMINATED · sponsor: **German CLL Study Group** · enrollment: 83 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **BIOLOGICAL:** Filgrastim
- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide
- **DRUG:** Mitoxantrone

## Key facts

- **NCT ID:** NCT00416910
- **Lead sponsor:** German CLL Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-07
- **Primary completion:** 2003-09
- **Final completion:** 2007-09
- **Target enrollment:** 83 (ACTUAL)
- **Why stopped:** low recruitment
- **Last updated:** 2016-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00416910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00416910, "Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00416910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*